RAC2 inhibition enhances tumor sensitivity to NK cell-mediated cytotoxicity
Journal for ImmunoTherapy of Cancer · 2025
DOI: 10.1136/jitc-2024-010931 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal for ImmunoTherapy of Cancer, 2025. Verfasst von Hui Guo und 16 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oncology in South China, Department of Experiment Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China. Hauptthemen laut MEDLINE: Killer Cells, Natural, Cytotoxicity, Immunologic, rac GTP-Binding Proteins. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Natural killer (NK) cells are recognized for their ability to kill tumor cells for tumor control, but tumor cells often develop resistance to evade NK cell-mediated cytotoxicity. Identification of molecular mechanisms by which tumor cells evade from NK cell-mediated killing may offer novel therapeutic strategies for potentiating NK-based cancer immunotherapy.
Methods
An in vitro tumor-NK cell co-culture system was employed to identify the most significantly altered genes in tumor cells following NK cell interaction. The cell death rate of tumor cells by NK cell exposure was quantified using flow cytometry. EL4 and HCT116 tumor models in C57BL/6, BALB/c-nu, and NOD/SCID mice were used for evaluating tumor growth differences induced by Rac2 knockdown or knockout. The cellular and molecular impact of Rac2 knockdown or knockout on the sensitivity of tumor cells to NK cell-mediated cytotoxicity was assessed using quantitative PCR, immunofluorescence, and mutation analysis.
Results
By screening expression levels of the Ras homology (Rho) GTPase family genes in tumor cells after co-culture with NK cells, we identified RAC2 as a key regulator of tumor cell resistance to NK cell-mediated cytotoxicity among the Rho GTPase family members. Furthermore, knockout of RAC2 in human colorectal cancer cells leads to increased tumor susceptibility to NK cell-mediated cytotoxicity in a xenograft tumor model. Mechanistically, the absence of RAC2 enhances tumor cell sensitivity to NK cell-mediated killing by facilitating cell–cell contact.
Conclusions
These findings indicate that the inhibition of RAC2 in tumor cells substantially enhances their susceptibility to NK cell-mediated cytotoxicity, thereby providing a potential therapeutic target for optimizing NK cell therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Oncology in South China, Department of Experiment Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China.
- Department of Medical Oncology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
- Department of Oncology, Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China.
- Guangzhou National Laboratory, Guangzhou, Guangdong, China.
- Department of Medical Oncology, Sun Yat-Sen Memorial Hospital, Guangzhou, Guangdong, China xiaxj@sysucc.org.cn liheping@mail.sysu.edu.cn.
- State Key Laboratory of Oncology in South China, Department of Experiment Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China xiaxj@sysucc.org.cn liheping@mail.sysu.edu.cn.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Guo, H., Hu, J., Wang, Z., Xu, F., Liu, Y., Cui, L., Zhang, H., Xie, C., Yao, R., Jin, H., Guo, Z., Wang, T., Li, L., Lin, Y., Wang, X., Li, H., & Xia, X. (2025). RAC2 inhibition enhances tumor sensitivity to NK cell-mediated cytotoxicity. Journal for ImmunoTherapy of Cancer. https://doi.org/10.1136/jitc-2024-010931
Vancouver
Guo H, Hu J, Wang Z, Xu F, Liu Y, Cui L, et al. RAC2 inhibition enhances tumor sensitivity to NK cell-mediated cytotoxicity. Journal for ImmunoTherapy of Cancer. 2025. doi:10.1136/jitc-2024-010931
BibTeX
@article{Guo2025,
author = {Guo, Hui and Hu, Jie and Wang, Zining and Xu, Feifei and Liu, Yongxiang and Cui, Lei and Zhang, Huanling and Xie, Chunyuan and Yao, Ruhui and Jin, Huan and Guo, Zixuan and Wang, Tiantian and Li, Lin and Lin, Yanxun and Wang, Xiaojuan and Li, Heping and Xia, Xiaojun},
title = {RAC2 inhibition enhances tumor sensitivity to NK cell-mediated cytotoxicity},
journal = {Journal for ImmunoTherapy of Cancer},
year = {2025},
doi = {10.1136/jitc-2024-010931}
}
EUVIMED